Virginia Harrod, MD, PhD

Clinical Assistant Professor

19962019
If you made any changes in Pure, your changes will be visible here soon.

Personal profile

Bio

Board Certifications: American Board of Pediatrics 2006, Pediatric Hematology, Oncology 2009

Undergraduate Education: The University of Texas at Austin 1992

Medical Education: The University of Texas Medical School at Houston 2001

Graduate: MD Anderson Cancer Center at the University of Texas Health Science Center at Houston at the Graduate School of Biomedical Sciences 1998

Residency: Children's Hospital of Austin 2004

Fellowship: St. Jude Children's Research Hospital 2007

Fingerprint Dive into the research topics where Virginia Harrod is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

Ganglioglioma Medicine & Life Sciences
Sickle Cell Anemia Medicine & Life Sciences
Iodine Radioisotopes Medicine & Life Sciences
Erythrocyte Inclusions Medicine & Life Sciences
Hydroxyurea Medicine & Life Sciences
Inbred BALB C Mouse Medicine & Life Sciences
Misonidazole Medicine & Life Sciences
Neuroepithelial Neoplasms Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1996 2019

Desmoplastic infantile ganglioglioma: A MAPK pathway-driven and microglia/macrophage-rich neuroepithelial tumor

Blessing, M. M., Blackburn, P. R., Krishnan, C., Harrod, V. L., Fritcher, E. G. B., Zysk, C. D., Jackson, R. A., Milosevic, D., Nair, A. A., Davila, J. I., Balcom, J. R., Jenkins, R. B., Halling, K. C., Kipp, B. R., Rao, A. A. N., Laack, N. N., Daniels, D. J., Macon, W. R. & Ida, C. M., Nov 1 2019, In : Journal of Neuropathology and Experimental Neurology. 78, 11, p. 1011-1021 11 p.

Research output: Contribution to journalArticle

Ganglioglioma
Neuroepithelial Neoplasms
Microglia
Gene Frequency
Macrophages
3 Citations (Scopus)

Novel BRAF alteration in desmoplastic infantile ganglioglioma with response to targeted therapy

Blessing, M. M., Blackburn, P. R., Balcom, J. R., Krishnan, C., Harrod, V., Zimmermann, M. T., Barr Fritcher, E. G., Zysk, C. D., Jackson, R. A., Nair, A. A., Jenkins, R. B., Halling, K. C., Kipp, B. R. & Ida, C. M., Nov 5 2018, In : Acta neuropathologica communications. 6, 1, 1 p.

Research output: Contribution to journalArticle

Open Access
Ganglioglioma
Therapeutics
25 Citations (Scopus)

Low-dose systemic thrombolytic therapy for deep vein thrombosis in pediatric patients

Leary, S. E., Harrod, V. L., De Alarcon, P. A. & Reiss, U. M., Mar 1 2010, In : Journal of Pediatric Hematology/Oncology. 32, 2, p. 97-102 6 p.

Research output: Contribution to journalArticle

Thrombolytic Therapy
Tissue Plasminogen Activator
Venous Thrombosis
Pediatrics
Thrombosis
6 Citations (Scopus)

Chemical and functional analysis of generic hydroxyurea formulations

Harrod, V., Howard, T., Abboud, M. R., Hankins, J., Lobo, C. & Ware, R. E., Jun 1 2008, In : Pediatric Hematology and Oncology. 25, 5, p. 423-429 7 p.

Research output: Contribution to journalArticle

Hydroxyurea
Sickle Cell Anemia
Capsules
Therapeutics
Pharmaceutical Preparations
42 Citations (Scopus)

Quantitative Analysis of Howell-Jolly Bodies in Children with Sickle Cell Disease

Harrod, V. L., Howard, T. A., Zimmerman, S. A., Dertinger, S. D. & Ware, R. E., Feb 1 2007, In : Experimental Hematology. 35, 2, p. 179-183 5 p.

Research output: Contribution to journalArticle

Erythrocyte Inclusions
Sickle Cell Anemia
Erythrocytes
Reticulocytes
Hydroxyurea